Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026)
Owlet's (OWLT) quarterly Net Income towards Common Stockholders came in at -$4.1 million in Q1 2026, down 336.96% year-on-year from $1.7 million in Q1 2025, and up 58.15% on a QoQ basis from -$9.9 million in Q4 2025.
Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$4.1 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 336.96% year-over-year to -$4.1 million in Q1 2026; TTM through Mar 2026 was -$48.6 million, a 179.48% decrease from a year earlier, with the FY2025 full-year figure at -$41.9 million, down 143.1% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$4.1 million, up from -$9.9 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for OWLT reached as high as $2.7 million in Q3 2025 and fell as low as -$37.2 million in Q2 2025.
- Historically, Net Income towards Common Stockholders has averaged -$10.7 million across 5 years, with a median of -$9.7 million in 2024.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 139.61% in 2025 and fell as far as 1286.54% in 2025.
- Year by year, Net Income towards Common Stockholders stood at -$19.5 million in 2022, then jumped by 57.85% to -$8.2 million in 2023, then declined by 17.8% to -$9.7 million in 2024, then slipped by 2.23% to -$9.9 million in 2025, then soared by 58.15% to -$4.1 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$4.1 million in Q1 2026, -$9.9 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Owlet | 145.72 Mn | 104.71 Mn | 12.24 Mn | -4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.14 Mn |
| Dec 31, 2025 | -9.90 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | -37.19 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -6.76 Mn |
| Jun 30, 2024 | -2.68 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | -8.22 Mn |
| Sep 30, 2023 | -6.96 Mn |
| Jun 30, 2023 | -9.79 Mn |
| Mar 31, 2023 | -12.52 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -5.34 Mn |